Scientific Review Reports Onset Or Worsening of Psoriasis Following COVID Shots
A 2023 scientific review published in the journal Biomedicines reported cases of new onset or worsening of psoriasis following COVID-19 shots.1 Patients in the scientific review either received mRNA-based biologics, including Pfizer/BioNTech Comirnaty or Moderna/NIAID’s Spikevax, or viral vectored vaccines that included AstraZeneca/Oxford University’s Vaxzevria or Johnson & Johnson/Janssen’s Ad26.COV2.S vaccine.2 Psoriasis is a chronic, […]
Meta Review of Autopsies Finds Link Between COVID Shots and Death
An independent meta review of autopsies on people who died after COVID-19 vaccination, published as a preprint in The Lancet online on July 5, 2023, found that 74 percent of the deaths were causally related to the shots. The review included 44 published papers that contained 325 autopsy cases and one necropsy case. According to […]
FDA Revokes EUA for Johnson & Johnson/Janssen’s COVID Vaccine
On June 1, 2023, the U.S. Food and Drug Administration (FDA) withdrew the Emergency Use Authorization (EUA) Johnson & Johnson/Janssen’s adenovirus vectored Ad26.COV2.S (also known as JNJ-78436735) COVID-19 vaccine that had been granted to the companies on Feb. 27, 2021. The FDA noted that Janssen requested the voluntary withdrawal of the EUA in a letter […]
More Women Bearing the Brunt of COVID Vaccine Reactions and Injury
Early reports to the Vaccine Adverse Event Reporting System (VAERS), a centralized federally operated vaccine reaction reporting system, after the messenger RNA (mRNA) COVID-19 shots were distributed under an Emergency Use Authorization (EUA in the United States revealed that women were reported to have experienced more severe allergic reactions to the COVID-19 shots than men. […]
Guillain-Barré Syndrome Linked to the RSV Vaccine
The potential risk of Guillain-Barré syndrome (GBS) developing after receipt of Pfizer’s respiratory experimental syncytial virus (RSV) vaccine have prompted the U.S. Food and Drug Administration (FDA) to request that Pfizer conduct a post-marketing safety study if the vaccine is approved for use in the United States this spring.1 The RSV vaccine manufactured by GlaxoSmithKline […]
Jacking Up the Price of Lemons: The COVID Vaccine Scam
In July 2020, the U.S. government ordered 100 million doses of Pfizer/BioNTech’s experimental BNT162b2 (now known as Comirnaty) messenger RNA (mRNA) COVID-19 biologic for $1.95 billion, or $19.50 per dose. A few months later in December, it followed up with a second order for another 100 million doses of the shot for the same price.1 […]
